KR960700245A - 메토트렉세이트 유도체[methotrexate derivative] - Google Patents
메토트렉세이트 유도체[methotrexate derivative]Info
- Publication number
- KR960700245A KR960700245A KR1019950702631A KR19950702631A KR960700245A KR 960700245 A KR960700245 A KR 960700245A KR 1019950702631 A KR1019950702631 A KR 1019950702631A KR 19950702631 A KR19950702631 A KR 19950702631A KR 960700245 A KR960700245 A KR 960700245A
- Authority
- KR
- South Korea
- Prior art keywords
- methotrexate derivative
- general formula
- methotrexate
- derivative
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
일반식
(식 중 R1, R2는 같거나 달라도 좋고, 수소원자 또는 탄소수 1~4의 저급 알킬기를나타낸다.)로 표시되는 화합물 및 그의 염, 및 그들의 1종 이상을 유효성분으로서 함유하는 항류머티즘제.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (2)
- 일반식(Ⅰ)(식 중 R1, R2는 같거나 달라도 좋고, 수소원자 또는 탄소수 1~4의 저급 알킬기를나타낸다.)로 표시되는 화합물 및 그의 염
- 제1항 기재의 일반식(Ⅰ)으로 표시되는 화합물 및 그의 염 중 1종 이상을 유효성분으로서 함유하는 항류 머티즘제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP92-362027 | 1992-12-25 | ||
JP36202792 | 1992-12-25 | ||
PCT/JP1993/001867 WO1994014810A1 (en) | 1992-12-25 | 1993-12-24 | Methotrexate derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960700245A true KR960700245A (ko) | 1996-01-19 |
KR100259742B1 KR100259742B1 (ko) | 2000-07-01 |
Family
ID=18475662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950702631A KR100259742B1 (ko) | 1992-12-25 | 1993-12-24 | 메토트렉세이트 유도체 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5728692A (ko) |
EP (1) | EP0676399B1 (ko) |
KR (1) | KR100259742B1 (ko) |
CN (1) | CN1037771C (ko) |
AT (1) | ATE184605T1 (ko) |
AU (1) | AU5715894A (ko) |
CA (1) | CA2152485A1 (ko) |
DE (1) | DE69326479T2 (ko) |
DK (1) | DK0676399T3 (ko) |
ES (1) | ES2140524T3 (ko) |
GR (1) | GR3031864T3 (ko) |
SG (1) | SG52733A1 (ko) |
WO (1) | WO1994014810A1 (ko) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0818199A4 (en) * | 1995-03-27 | 2002-08-14 | Chugai Pharmaceutical Co Ltd | MEDICINE CONTAINING METHOTREXATE DERIVATIVE |
AU1942497A (en) * | 1996-03-19 | 1997-10-10 | Chugai Seiyaku Kabushiki Kaisha | Uveitis remedy |
WO2000000492A1 (fr) * | 1998-06-26 | 2000-01-06 | Chugai Seiyaku Kabushiki Kaisha | DERIVE D'ACIDE L-α-AMINOADIPIQUE EN POUDRE FINE, PREPARATIONS SOLIDES ORALES CONTENANT LEDIT DERIVE ET PROCEDE DE TRAITEMENT DE POUDRES EN VRAC |
AU6594000A (en) * | 1999-08-17 | 2001-03-13 | Chugai Seiyaku Kabushiki Kaisha | Remedies for myocardial infarction |
US20060039985A1 (en) * | 2004-04-27 | 2006-02-23 | Bennett David B | Methotrexate compositions |
US7741317B2 (en) * | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
WO2009114325A2 (en) | 2008-03-03 | 2009-09-17 | Tosk, Incorporated | Methotrexate adjuvants to reduce toxicity and methods for using the same |
EP2527322A1 (en) | 2011-05-24 | 2012-11-28 | Noscira, S.A. | Carbamyl alkylphenyl disulfide derivatives and their therapeutic uses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2784670B2 (ja) * | 1989-08-09 | 1998-08-06 | 株式会社シーエスケイ | パチンコ景品交換システム |
JPH04368385A (ja) * | 1991-06-12 | 1992-12-21 | Chugai Pharmaceut Co Ltd | 新規メトトレキセート誘導体 |
AU8333291A (en) * | 1990-08-14 | 1992-03-17 | Chugai Seiyaku Kabushiki Kaisha | Novel methotrexate derivative |
TW223637B (ko) * | 1992-01-27 | 1994-05-11 | Chugai Pharmaceutical Co Ltd | |
JP3281099B2 (ja) * | 1992-02-13 | 2002-05-13 | 中外製薬株式会社 | 抗リウマチ剤 |
-
1993
- 1993-12-24 CN CN93121089A patent/CN1037771C/zh not_active Expired - Fee Related
- 1993-12-24 DK DK94903046T patent/DK0676399T3/da active
- 1993-12-24 ES ES94903046T patent/ES2140524T3/es not_active Expired - Lifetime
- 1993-12-24 AU AU57158/94A patent/AU5715894A/en not_active Abandoned
- 1993-12-24 CA CA002152485A patent/CA2152485A1/en not_active Abandoned
- 1993-12-24 SG SG1996008496A patent/SG52733A1/en unknown
- 1993-12-24 AT AT94903046T patent/ATE184605T1/de not_active IP Right Cessation
- 1993-12-24 DE DE69326479T patent/DE69326479T2/de not_active Expired - Fee Related
- 1993-12-24 KR KR1019950702631A patent/KR100259742B1/ko not_active IP Right Cessation
- 1993-12-24 WO PCT/JP1993/001867 patent/WO1994014810A1/ja active IP Right Grant
- 1993-12-24 EP EP94903046A patent/EP0676399B1/en not_active Expired - Lifetime
-
1995
- 1995-12-24 US US08/454,290 patent/US5728692A/en not_active Expired - Fee Related
-
1999
- 1999-11-17 GR GR990402959T patent/GR3031864T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3031864T3 (en) | 2000-02-29 |
EP0676399B1 (en) | 1999-09-15 |
WO1994014810A1 (en) | 1994-07-07 |
US5728692A (en) | 1998-03-17 |
DE69326479T2 (de) | 2000-03-02 |
EP0676399A4 (en) | 1996-04-17 |
ES2140524T3 (es) | 2000-03-01 |
DE69326479D1 (de) | 1999-10-21 |
DK0676399T3 (da) | 2000-03-20 |
CN1093365A (zh) | 1994-10-12 |
ATE184605T1 (de) | 1999-10-15 |
CN1037771C (zh) | 1998-03-18 |
EP0676399A1 (en) | 1995-10-11 |
CA2152485A1 (en) | 1994-07-07 |
AU5715894A (en) | 1994-07-19 |
KR100259742B1 (ko) | 2000-07-01 |
SG52733A1 (en) | 1998-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920021506A (ko) | 19-노르 비타민 d 화합물 합성용 중간체 | |
KR920701200A (ko) | 신규의 4h-3,1-벤조옥사진-4-온 유도체 | |
KR960704919A (ko) | 신규인 펩티드 유도체 (novel peptide derivative) | |
DE69012515D1 (de) | Haarfärbemittel. | |
KR940021059A (ko) | 지질 대사 개선제 | |
KR890002198A (ko) | 유기 규소 화합물 | |
KR960007592A (ko) | 신규한 피롤로카바졸 | |
CA2128205A1 (en) | Methotrexate derivatives | |
KR910019977A (ko) | 카르바졸 화합물 | |
KR900004820A (ko) | 안정화된 합성수지조성물 | |
KR960700245A (ko) | 메토트렉세이트 유도체[methotrexate derivative] | |
KR860700250A (ko) | 신규 아미딘 화합물 | |
KR900001673A (ko) | N-치환 아미드 유도체 | |
KR920702685A (ko) | 4,6-o- 히드록시포스포릴글루코사민 유도체 | |
KR890003718A (ko) | N- 알킬벤젠 술포닐 카르바모일-5- 클로로이소티아졸 유도체 및 살미생물제 | |
KR890008151A (ko) | 키놀린 카르복산의 유도체 | |
KR890005076A (ko) | 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제 | |
KR900018083A (ko) | 에폭시숙신산 유도체 | |
KR940014340A (ko) | 3-아자비시클로[3.l.0]헥산-2-온 유도체와 제초제 활성 성분으로 이를 포함하는 제조체 조성물 | |
KR920002613A (ko) | 이환성 함유 황화합물 | |
KR890002179A (ko) | 세펨 유도체 | |
KR890005096A (ko) | 빈카민산 유도체 | |
KR860008184A (ko) | 디옥솔로벤조이소옥사졸 유도체의 제법 | |
KR860007876A (ko) | 제초제 조성물 | |
KR940002256A (ko) | 세펨 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
FPAY | Annual fee payment |
Payment date: 20040127 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |